Spontaneous regression of primary abdominal wall desmoid tumors: More common than previously thought

Annals of Surgical Oncology

Volumn 20, Issue 13, 2013, Pages 4096-4102

  Bonvalot, Sylvie ^a   Ternes, Nils ^a   Fiore, Marco ^b   Bitsakou, Georgina ^a   Colombo, Chiara ^b   Honore, Charles ^a   Marrari, Andrea ^b   Cesne, Axel Le ^a   Perrone, Federica ^b   Dunant, Ariane ^a   Gronchi, Alessandro ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NAVELBINE;

ABDOMINAL WALL; ABDOMINAL WALL DESMOID TUMOR; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER REGRESSION; CANCER SIZE; CANCER SURGERY; CONSERVATIVE TREATMENT; DESMOID TUMOR; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATION; REMISSION; RISK ASSESSMENT; SURGICAL MESH; YOUNG ADULT;

ABDOMINAL NEOPLASMS; ABDOMINAL WALL; ADOLESCENT; ADULT; AGED; FEMALE; FIBROMATOSIS, ABDOMINAL; FIBROMATOSIS, AGGRESSIVE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; YOUNG ADULT;

EID: 84892178804     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3197-x     Document Type: Article

References (38)

1. Peng PD, Hyder O, Mavros MN, et al. Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. Ann Surg Oncol. 2012;19:4036-42.
2. Mullen JT, Delaney TF, Kobayashi WK, et al. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol. 2012;19:4028-35.
3. von Mehren M, Benjamin RS, Bui MM, et al. Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2012;10:951-60.
4. ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23(Suppl 7):vii92-9.
5. Bonvalot S, Eldweny H, Haddad V, et al. Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol 2008;34:462-8.
6. Fiore M, Rimareix F, Mariani L, et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol. 2009;16:2587-93.
7. Salas S, Dufresne A, Bui B, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol. 2011;29:3553-8.
8. Gronchi A, Raut CP. Optimal approach to sporadic desmoid tumors: from radical surgery to observation. Time for a consensus? Ann Surg Oncol. 2012;19:3995-7.
9. Kasper B, Strobel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist. 2011;16:682-93.
10. Holme H, Westbury CB, Morgenstern D, et al. An important role for initial observation in the management of paediatric desmoid fibromatosis. Clin Oncol (R Coll Radiol). 2013;25:e16.
11. Honeyman JN, Theilen TM, Knowles MA, et al. Desmoid fibromatosis in children and adolescents: a conservative approach to management. J Pediatr Surg. 2013;48:62-6.
12. Nishida Y, Tsukushi S, Urakawa H, et al. Is it possible to identify clinically useful prognostic groups for patients with desmoid tumors? J Clin Oncol. 2012;30:1390.
13. Reitamo JJ, Hayry P, Nykyri E, et al. The desmoid tumor. I. Incidence, sex-, age and anatomical distribution in the Finnish population. Am J Clin Pathol. 1982;77:665-73.
14. Gronchi A, Casali PG, Mariani L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol. 2003;21:1390-7.
15. Stoeckle E, Coindre JM, Longy M, et al. A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases. Eur J Surg Oncol. 2009;35:129-34.
16. Bonvalot S, Desai A, Coppola S, et al. The treatment of desmoid tumors: a stepwise clinical approach. Ann Oncol. 2012;23(Suppl 10):x158-66.
17. Bertani E, Chiappa A, Testori A, et al. Desmoid tumors of the anterior abdominal wall: results from a monocentric surgical experience and review of the literature. Ann Surg Oncol. 2009;16:1642-9.
18. Catania G, Ruggeri L, Iuppa G, et al. Abdominal wall reconstruction with intraperitoneal prosthesis in desmoid tumors surgery. Updates Surg. 2012;64:43-8.
19. Sutton RJ, Thomas JM. Desmoid tumours of the anterior abdominal wall. Eur J Surg Oncol. 1999;25:398-400.
20. UICC. Tumor of bone and soft tissues. R classification. In: Sobin LH, Wittekind CH, editors. TNM classification of malignant tumours. 6th ed. New York: Wiley; 2002. p. 110.
21. van Elteren PH. On the combination of independent two-sample tests of Wilcoxon. Bull Int Stat Inst. 1960;37:351-61.
22. Pintilie M. Analysing and interpreting competing risk data. Stat Med. 2007;26:1360-7.
23. Francis WP, Zippel D, Mack LA, et al. Desmoids: a revelation in biology and treatment. Ann Surg Oncol. 2009;16:1650-4.
24. Pencavel T, Strauss DC, Thomas JM, et al. The surgical management of soft tissue tumours arising in the abdominal wall. Eur J Surg Oncol. 2010;36:489-95.
25. Yezhelyev MV, Deigni O, Losken A. Management of fullthickness abdominal wall defects following tumor resection. Ann Plast Surg. 2012;69:186-91.
26. van Persijn van Meerten EL, Gelderblom H, Bloem JL. RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline. Eur Radiol. 2010;20:1456-67.
27. Hansmann A, Adolph C, Vogel T, et al. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer. 2004;100:612-20.
28. Benson JR, Mokbel K, Baum M. Management of desmoid tumours including a case report of toremifene. Ann Oncol. 1994;5:173-7.
29. de Camargo VP, Keohan ML, D'Adamo DR, et al. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer. 2010;116:2258-65.
30. Garbay D, Le Cesne A, Penel N. Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG). Ann Oncol. 2012;23:182-6.
31. Lev D, Kotilingam D, Wei C, et al. Optimizing treatment of desmoid tumors. J Clin Oncol. 2007;25:1785-91.
32. Nuyttens JJ, Rust PF, Thomas CR Jr, et al. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles Cancer. 2000;88:1517-23.
33. Ballo MT, Zagars GK, Pollack A, et al. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999;17:158-67.
34. Spear MA, Jennings LC, Mankin HJ, et al. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys. 1998;40:637-45.
35. Rock MG, Pritchard DJ, Reiman HM, et al. Extra-abdominal desmoid tumors. J Bone Joint Surg Am. 1984;66:1369-74.
36. Fiore M, Coppola S, Cannel AJ. Desmoid-type fibromatosis and pregnancy. A multi-institutional analysis of recurrence and obstetric risk. Ann Surg. doi:10.1097/SLA.0000000000000224.
37. Matono H, Tamiya S, Yokoyama R, et al. Abnormalities of the Wnt/b-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between b-catenin widespread nuclear expression and VEGF overexpression. Histopathology. 2011;59:368-75.
38. Lazar AJ, Tuvin D, Hajibashi S, et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol. 2008;173:1518-27.